SHENZHEN, GUANGDONG, CHINA, February 3, 2026 /EINPresswire.com/ -- Future Trends: Ansix Tech Limited, established in ...

Foundry-logic demand remains healthy at leading-edge nodes, with improving momentum in the U.S. and Taiwan and increased activity in Korea. China demand & export controls -- Demand in China is "mixed ...

ITAT Delhi held that notice under Section 148 issued before obtaining mandatory approval under Section 151 is invalid. Since ...

ITAT Delhi held that a public charitable trust cannot be taxed at the Maximum Marginal Rate under Section 167B. The Tribunal directed that income be taxed at normal slab rates applicable to an ...

Magna delivered solid fourth-quarter results, reflecting disciplined execution, and improved operating performance. Year-over-year comparison (fourth quarter of 2025 versus fourth quarter of 2024): ...

2. Core Strengths: Why Taiyuan Simis Leads the Global Market Established in 2004, but rooted in a collective history spanning over 40 years, Taiyuan Simis has built a production ecosystem that few can ...

In ALIGN study, Vanrafia (atrasentan) showed positive difference in eGFR change from baseline vs. placebo at Week 136, 4 weeks after study treatment ended1Results favored Vanrafia across multiple ...

Magna delivered solid fourth-quarter results, reflecting disciplined execution, and improved operating performance. Year-over ...

In ALIGN study, Vanrafia (atrasentan) showed positive difference in eGFR change from baseline vs. placebo at Week 136, 4 weeks after study treatment ended1Results favored Vanrafia across multiple ...

Discover effective strategies to enhance your company's net profit margin by increasing sales revenue and reducing ...

(PRESS RELEASE) BASEL, 13-Feb-2026 — / EuropaWire / — Novartis has announced final Phase III results from the ALIGN study evaluating Vanrafia (atrasentan) in adults with IgA nephropathy (IgAN), ...

Bismuth quadruple therapy (BQT) is the most cost-effective first-line therapy for treating Helicobacter ( H) pylori infection, from a United States (US) health care payer perspective. These findings ...